How many employees does Assembly Biosciences, Inc. have?

Assembly Biosciences, Inc. reported 73 employees for the fiscal year ending Dec 2025, in the annual report it filed on March 19, 2026. That is unchanged from a year earlier.

What is Assembly Biosciences, Inc.'s revenue per employee?

Assembly Biosciences, Inc. brought in $72.3M of revenue in fiscal Dec 2025, which is $990K per employee. That ranks 35 of 108 companies we track in Biotechnology, where the median is $459K.

Where do these numbers come from?

Employee counts and revenue are taken from each company's own annual report (Form 10-K). Open roles are counted from the company's public job board where we have matched one. Companies report headcount once a year, sometimes rounded, so small changes can be noise.

Company data

Assembly Biosciences, Inc. employees and revenue per employee

ASMB · Biotechnology · $466M market cap

Assembly Biosciences, Inc. had 73 employees at the end of fiscal Dec 2025, unchanged from a year earlier. Revenue for the year was $72.3M, up 153.5% from a year earlier, or $990K per employee. Revenue held up or grew while headcount stayed flat or fell.

Employees

+0.0% YoY

Revenue

$72.3M

+153.5% YoY

Revenue / employee

$990K

Peer median $459K

Rank in industry

35 of 108

Biotechnology

Headcount against revenue

Both lines start at 100 in the first year we hold, so you can see which one grew faster.

EmployeesRevenueIndexed to 100 in Dec 2017

Hover a year for the numbers.

ASMB employees and revenue by fiscal year
Year ending	Employees	Revenue	Per employee	Staff YoY	Revenue YoY
Dec 2025	73	$72.3M	$990K	+0.0%	+153.5%
Dec 2024	73	$28.5M	$391K	+12.3%	+298.2%
Dec 2023	65	$7.2M	$110K	—	—
Dec 2021	102	$6.3M	$61K	-26.6%	-92.1%
Dec 2020	139	$79.1M	$569K	+20.9%	+395.6%
Dec 2019	115	$16.0M	$139K	+21.1%	+7.8%
Dec 2018	95	$14.8M	$156K	+20.3%	+64.1%
Dec 2017	79	$9.0M	$114K	—	—

Open roles: we have not matched a verified job board for this company yet.

Employees, last six fiscal years

Revenue per employee, last six fiscal years

Assembly Biosciences, Inc. against similar companies

The closest industry peers by revenue, from Biotechnology.

Company	Employees	Revenue	Revenue / employee	Shape
ASMB Assembly Biosciences, Inc.	73	$72.3M	$990K	Leaner
ARCT Arcturus Therapeutics Holdings Inc.	106	$67.2M	$634K	Contracting
ENTA Enanta Pharmaceuticals, Inc.	120	$65.3M	$544K	Contracting
VRDN Viridian Therapeutics, Inc.	252	$70.8M	$281K	Efficient growth
KURA Kura Oncology, Inc.	260	$67.5M	$260K	Hiring ahead
NUVB Nuvation Bio Inc.	298	$62.9M	$211K	Efficient growth
MGTX MeiraGTx Holdings plc	400	$81.4M	$203K	Efficient growth
VIR Vir Biotechnology, Inc.	367	$68.6M	$187K	Contracting
NTLA Intellia Therapeutics, Inc.	377	$67.7M	$179K	Leaner

Every Healthcare company

Questions about Assembly Biosciences, Inc.

How many employees does Assembly Biosciences, Inc. have?: Assembly Biosciences, Inc. reported 73 employees for the fiscal year ending Dec 2025, in the annual report it filed on March 19, 2026. That is unchanged from a year earlier.
What is Assembly Biosciences, Inc.'s revenue per employee?: Assembly Biosciences, Inc. brought in $72.3M of revenue in fiscal Dec 2025, which is $990K per employee. That ranks 35 of 108 companies we track in Biotechnology, where the median is $459K.
Where do these numbers come from?: Employee counts and revenue are taken from each company's own annual report (Form 10-K). Open roles are counted from the company's public job board where we have matched one. Companies report headcount once a year, sometimes rounded, so small changes can be noise.

Free game

Think you can pick better than the S&P 500?

Pick 15 stocks, lock them in, and we score them against the index every trading day for ten years. Free, with a public leaderboard.

Enter the challenge

More data

Compare ASMB with the rest of the market

See who earns the most per employee, who is hiring, and who is cutting, across every company we track.

Leaderboard Healthcare

Source: employee counts and revenue as stated in Assembly Biosciences, Inc.'s annual reports (Form 10-K), latest filed March 19, 2026. This is data, not a recommendation to buy or sell ASMB.